subject: UMLS:C1831753

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UMLS:C1831753

subject_name: pNGVL3-hICD Vaccine

object_name: Stage IV Ovarian Cancer AJCC v6 and v7

tested_intervention: unsure


subject: UMLS:C1831753

object_name: Ovarian cancer stage IV


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Stage III Ovarian Germ Cell Tumor AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Ovarian germ cell cancer stage IV


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UNII:P1DFX74SQ8

subject_name: ZUBERITAMAB

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5420975


subject: GTOPDB:12989

subject_name: toripalimab

object_name: intrahepatic cholangiocarcinoma


subject: UNII:8JXN261VVA


subject: CHEBI:31550

subject_name: Patupilone

object_name: Metastatic castration-resistant prostate cancer

tested_intervention: yes


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: skin melanoma


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: PUBCHEM.COMPOUND:132451761

subject_name: Forteo

object_name: autosomal dominant hypocalcemia


subject: PUBCHEM.COMPOUND:132451761

object_name: Hypocalcemia


subject: PUBCHEM.COMPOUND:132451761

object_name: Serum calcium below normal (finding)


subject: PUBCHEM.COMPOUND:132451761

object_name: Hypocalcemia, CTCAE


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: UMLS:C0376564


subject: PR:000001026

subject_name: lymphocyte antigen 75

object_name: primary peritoneal carcinoma


subject: PR:000001026

object_name: papillary serous cystadenocarcinoma


subject: PR:000001026

object_name: peritoneal carcinoma


subject: PR:000001026

object_name: fallopian tube carcinoma


subject: PR:000001026

object_name: ovarian cancer


subject: PR:000001026

object_name: ovarian carcinoma


subject: PR:000001026

object_name: malignant epithelial tumor of ovary


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: UniProtKB:O60449


subject: GTOPDB:8221

subject_name: epacadostat


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: GTOPDB:8221


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: DNA Virus Infections


subject: CHEBI:465284

object_name: Herpesviridae infectious disease


subject: UNII:A35F525WBG

subject_name: PEMVIDUTIDE


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: small cell lung carcinoma


subject: UNII:49I8A1C26Y

subject_name: Lisdexamfetamine sulfate

object_name: multiple sclerosis


subject: UMLS:C4548896

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C1260201

subject_name: AMG 073

object_name: end stage renal failure


subject: UMLS:C1260201

object_name: Chronic uremia


subject: DRUGBANK:DB12786

subject_name: Alvircept sudotox

object_name: HIV infection


subject: UNII:Q67R7N520V

subject_name: avircept sudotox


subject: UMLS:C3274844

object_name: Paresis


subject: UMLS:C3274844

object_name: Muscle weakness


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Intraventricular hemorrhage


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: cystic fibrosis


subject: UMLS:C3886793

object_name: cocaine dependence


subject: CHEBI:6121

subject_name: Ketamine

object_name: chronic pain syndrome


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:16044

subject_name: L-methionine residue

object_name: lung cancer


subject: CHEBI:16044

object_name: lung neoplasm


subject: CHEBI:16044

object_name: lung carcinoma


subject: CHEBI:16811

subject_name: Racemethionine


subject: CHEBI:16811


subject: CHEBI:16811


subject: CHEBI:231693

subject_name: Capmatinib

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:231693

object_name: MET Gene Mutation


subject: CHEBI:52717

subject_name: Bortezomib

object_name: multicentric Castleman disease


subject: CHEBI:52717

object_name: idiopathic multicentric Castleman disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:15544

subject_name: Alprostadil

object_name: prostate carcinoma


subject: CHEBI:15544

object_name: prostate cancer


subject: CHEBI:15544

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:15544

object_name: Prostate cancer stage I


subject: CHEBI:15544

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:15544

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:15544

object_name: Stage II Prostate Cancer AJCC v6


subject: CHEBI:15544

object_name: Stage II Prostate Cancer AJCC v8


subject: CHEBI:15544

object_name: Carcinoma of the prostate stage II


subject: CHEBI:15544

object_name: Stage II Prostate Cancer AJCC v7


subject: CHEBI:8774

subject_name: Ramipril

object_name: type 1 diabetes mellitus 1


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Fatty Liver


subject: UNII:Z633861EIM

subject_name: Asfotase alfa

object_name: Severe COVID-19 Infection


subject: UNII:Z633861EIM

object_name: Severe dysplasia


subject: UNII:Z633861EIM

object_name: Intensity and Distress 5


subject: UNII:Z633861EIM

object_name: Severe Adverse Event


subject: UNII:Z633861EIM

object_name: Allergy Severity - Severe


subject: UNII:Z633861EIM

object_name: Shock


subject: UNII:283FTA936D

object_name: ulcerative colitis


subject: UNII:283FTA936D

object_name: inflammatory bowel disease 1


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Neck Carcinoma


subject: MESH:C079198

object_name: head and neck cancer


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: multicentric Castleman disease


subject: UNII:I031V2H011

object_name: Castleman disease


subject: UNII:I031V2H011

object_name: localized Castleman disease


subject: CHEBI:63635

subject_name: Valganciclovir


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: UMLS:C0919075


subject: UMLS:C0919075


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:10110


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Primary malignant neoplasm


subject: UMLS:C0919079

object_name: Malignant obstetric neoplasm


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:6801

subject_name: Metformin

object_name: inflammatory bowel disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: chronic hepatitis C virus infection


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: hepatitis C


subject: UMLS:C3536908


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: vasculitis


subject: UNII:B72HH48FLU

object_name: Vasculitis, CTCAE


subject: UNII:B72HH48FLU

object_name: Behcet disease


subject: CHEBI:35482

subject_name: opioid analgesic

object_name: carpal tunnel syndrome


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: glioma


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: malignant glioma


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: Recurrent Brain Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: Childhood Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL1089636

object_name: adult glioblastoma


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: UMLS:C2604057


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Postoperative infection


subject: CHEBI:51254

object_name: Structure of ileal conduit


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:3515


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: UMLS:C0812735


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:63607


subject: CHEBI:184472

subject_name: Nitrofurantoin


subject: CHEBI:184472


subject: CHEMBL.COMPOUND:CHEMBL1650818

subject_name: pivmecillinam


subject: CHEMBL.COMPOUND:CHEMBL1650818


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:6775

subject_name: Mesalazine

object_name: Acne inversa


subject: UNII:8Z28M5SX0X

subject_name: Zandelisib

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:8Z28M5SX0X

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:11612L5SPI

object_name: type 2 diabetes mellitus


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: malignant pleural mesothelioma


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Metastatic Oral Cavity Carcinoma


subject: CHEBI:41423

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785

object_name: Recurrent Oral Cavity Carcinoma


subject: CHEBI:114785


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:71255

subject_name: Asenapine

object_name: paranoid schizophrenia


subject: CHEBI:71255

object_name: Schizophrenia, Disorganized


subject: CHEBI:71255

object_name: Undifferentiated schizophrenia


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: CHEBI:71256


subject: CHEBI:71256


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: colon carcinoma


subject: UNII:PQX0D8J21J

object_name: colon cancer


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Extreme immaturity


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: eosinophilic esophagitis


subject: UNII:71492GE1FX

object_name: Eosinophilic infiltration of the esophagus


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: Intraoperative Hemorrhage


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UMLS:C4048712

subject_name: factor IX complex


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:13085

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: GTOPDB:13085

object_name: malignant tumor of nasopharynx


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UNII:AD0O8X2QJR

subject_name: Ubrogepant

object_name: migraine


subject: UNII:AD0O8X2QJR

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:W6I5QDT7QI

subject_name: Netarsudil

object_name: bullous keratopathy


subject: UNII:W6I5QDT7QI

object_name: Corneal epithelial edema


subject: UMLS:C0731996

subject_name: metronidazole cream

object_name: Erythematotelangiectatic Rosacea


subject: CHEBI:31824

subject_name: Mesna

object_name: germ cell tumor


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:90227

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cocaine abuse


subject: CHEBI:74088

object_name: asthma


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: UNII:7DT29059VX

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:8871

subject_name: Risperidone

object_name: borderline personality disorder


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C2346820

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C2346820


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001


subject: UMLS:C4287773


subject: UNII:8BR2SOL3L1

object_name: Metastatic malignant neoplasm to bone


subject: DRUGBANK:DB12813

subject_name: Radium Ra-223


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: inborn error of immunity


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: hemangioma


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:8382

subject_name: Prednisone

object_name: Facial edema


subject: CHEBI:8382

object_name: Facial swelling (finding)


subject: CHEBI:8382

object_name: Impacted tooth


subject: CHEBI:8382

object_name: Tooth extraction status NOS


subject: CHEBI:8382

object_name: Displaced tooth


subject: CHEBI:8382

object_name: Tooth avulsion


subject: DRUGBANK:DB11097

subject_name: Plantago seed

object_name: kidney disorder


subject: DRUGBANK:DB11097

object_name: impaired renal function disease


subject: CHEBI:165446

subject_name: Psyllic acid


subject: CHEBI:165446


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: urethral stricture


subject: CHEBI:3215

object_name: Urethral stricture


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: sleep apnea


subject: CHEBI:127342

object_name: Sleep Apnea, CTCAE


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL


subject: PUBCHEM.COMPOUND:86217377


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:144551


subject: CHEBI:8378

subject_name: Prednisolone

object_name: schizophrenia


subject: CHEBI:8378

object_name: schizophreniform disorder


subject: CHEBI:8378

object_name: schizoaffective disorder


subject: CHEBI:8378

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Viral upper respiratory tract infection


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Wet age-related macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL4297703

object_name: arteriosclerosis disorder


subject: CHEMBL.COMPOUND:CHEMBL4297703

object_name: atherosclerosis


subject: UMLS:C3884669


subject: UMLS:C3884669


subject: PUBCHEM.COMPOUND:127236

object_name: POEMS syndrome


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: UMLS:C5854565

subject_name: IL-12/Anti-CTLA-4 Monoclonal Antibody-expressing Oncolytic Viral Vector TG6050

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: Osteopenia


subject: UMLS:C3897616

subject_name: Shu Yu Wan Formula

object_name: Metastatic non-small cell lung cancer


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: digestive system neoplasm


subject: GTOPDB:9758

object_name: digestive system disorder


subject: GTOPDB:9758

object_name: gastric neoplasm


subject: GTOPDB:9758

object_name: cancer


subject: GTOPDB:9758

object_name: stomach disease


subject: GTOPDB:9758

object_name: neoplasm


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: PR:000013574


subject: PR:000013574


subject: PR:000013574


subject: PR:000013574


subject: PR:000013574


subject: CHEBI:27594

subject_name: Graphite

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:108123

subject_name: Entonox

object_name: pain agnosia


subject: PUBCHEM.COMPOUND:108123

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Hunter Syndrome


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:188072

object_name: bipolar disorder


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Peptic Ulcer


subject: CHEBI:7915

object_name: Reflux


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227

object_name: Heartburn


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: CHEBI:63610

subject_name: Misoprostol

object_name: abortion in second trimester


subject: PUBCHEM.COMPOUND:9904502

subject_name: 7-KETO DEHYDROEPIANDROSTERONE

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:9904502

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:231666

object_name: Atopic rhinitis


subject: CHEBI:231666

object_name: Hay fever


subject: CHEBI:60791

subject_name: Xylocard

object_name: infertility


subject: CHEBI:6456

subject_name: Lidocaine


subject: GTOPDB:2479

subject_name: HCl


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: UMLS:C4053677

object_name: ovarian cancer


subject: UMLS:C4053677

object_name: ovarian neoplasm


subject: UMLS:C4053677

object_name: ovarian carcinoma


subject: CHEBI:15940

subject_name: Niacin

object_name: periodontitis


subject: CHEBI:15940

object_name: Periodontal inflammation


subject: CHEBI:15940

object_name: Periodontal Attachment Loss


subject: CHEBI:15940

object_name: periodontal disorder


subject: CHEBI:15633

subject_name: dihydrofolate


subject: CHEBI:15633


subject: CHEBI:15633


subject: CHEBI:15633


subject: CHEBI:176842

subject_name: vitamin B9


subject: CHEBI:176842


subject: CHEBI:176842


subject: CHEBI:176842


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:50114

subject_name: estrogen

object_name: Weight Gain


subject: CHEBI:50114

object_name: Weight Gain, CTCAE


subject: CHEBI:50114

object_name: Abdominal obesity


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist


subject: UMLS:C1268855


subject: UMLS:C1268855


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: adult lymphoma


subject: UNII:M487QF2F4V

object_name: lymphoma


subject: UNII:M487QF2F4V

object_name: pediatric lymphoma


subject: UNII:M487QF2F4V

object_name: non-Hodgkin lymphoma


subject: UNII:M487QF2F4V

object_name: Hodgkin Disease


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Hypoxic ischemic encephalopathy of newborn


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: rheumatoid arthritis


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: juvenile dermatomyositis


subject: CHEBI:8228

object_name: myositis


subject: CHEBI:8228

object_name: Myositis, CTCAE 5.0


subject: CHEBI:8228

object_name: inclusion body myositis


subject: CHEBI:8228

object_name: musculoskeletal system disorder


subject: CHEBI:8228

object_name: neuromuscular disease


subject: CHEBI:8228

object_name: nervous system disorder


subject: CHEBI:8228

object_name: myopathy


subject: CHEBI:8228

object_name: muscle tissue disorder


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: type 2 diabetes mellitus


subject: CHEBI:28793

object_name: Insulin resistance


subject: DRUGBANK:DB19271

subject_name: Yeast beta-D-glucan


subject: DRUGBANK:DB19271


subject: DRUGBANK:DB10666

subject_name: Arabica coffee bean


subject: DRUGBANK:DB10666


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: primary biliary cholangitis


subject: CHEBI:201431

object_name: autoimmune hepatitis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: UMLS:C0260264

subject_name: steroid drugs

object_name: septic shock


subject: UNII:83U7957287

object_name: Advanced cancer


subject: CHEBI:8382

subject_name: Prednisone

object_name: Geographic atrophy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIC Colon Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Colon Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Colon Cancer AJCC v7


subject: UMLS:C0445115

subject_name: Normal saline

object_name: respiratory failure


subject: UMLS:C0445115

object_name: Respiratory Failure, CTCAE


subject: CHEBI:232592

object_name: Advanced breast cancer


subject: CHEBI:139355

subject_name: Methacetin methoxy-C-13

object_name: liver failure


subject: CHEBI:25812

subject_name: Ozone

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:25812

object_name: neuralgia


subject: CHEBI:25812

object_name: Pain Disorder


subject: UMLS:C3257792

subject_name: Bydureon

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3257792

object_name: obesity


subject: UMLS:C3257792

object_name: Obesity, CTCAE


subject: CHEBI:95021

subject_name: pemetrexed

object_name: diffuse large B-cell lymphoma


subject: CHEBI:63724


subject: UMLS:C2348949

object_name: basal cell carcinoma


subject: UMLS:C2348949

object_name: skin basal cell carcinoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: High grade glioma


subject: CHEBI:70839

object_name: Pontine Tumors


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate

object_name: Diabetes


subject: PUBCHEM.COMPOUND:425400

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:425400


subject: PUBCHEM.COMPOUND:425400


subject: PUBCHEM.COMPOUND:425400


subject: PUBCHEM.COMPOUND:425400

object_name: Fatty Liver


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: Cervical intraepithelial neoplasia grade 2


subject: CHEBI:17549

object_name: human papilloma virus infection


subject: UMLS:C5669600

subject_name: Ivonescimab

object_name: Resectable non-small cell lung cancer


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: ocular melanoma


subject: MESH:C520255

object_name: uveal melanoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C5557412

subject_name: Pol Theta Inhibitor ART4215

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5557412

object_name: Embolism, Tumor


subject: UMLS:C5557412

object_name: Neoplasm Metastasis


subject: UMLS:C5557412

object_name: Advanced cancer


subject: UMLS:C5557412

object_name: Childhood Breast Carcinoma


subject: UMLS:C5557412

object_name: breast carcinoma


subject: UMLS:C5557412

object_name: breast cancer


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: psoriasis


subject: UMLS:C0359949

subject_name: epinephrine / lidocaine

object_name: Post-Operative Pain


subject: CHEBI:2668

subject_name: Amlodipine

object_name: stroke disorder


subject: CHEBI:2668

object_name: cerebrovascular disorder


subject: CHEBI:2668

object_name: Stroke (heart beat)


subject: CHEBI:2668

object_name: Stroke, CTCAE


subject: CHEBI:151315

subject_name: Heparin

object_name: autoimmune polyendocrinopathy


subject: CHEBI:151315

object_name: antiphospholipid syndrome


subject: CHEBI:151315

object_name: habitual spontaneous abortion


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:10033


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: endogenous depression


subject: CHEBI:47808

object_name: major depressive disorder


subject: UMLS:C5908019

subject_name: Oncolytic HSV-1 Expressing IL-2 and IL-12 KB707

object_name: metastatic melanoma


subject: UMLS:C5908019

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C5908019

object_name: melanoma


subject: UMLS:C5908019

object_name: skin melanoma


subject: UMLS:C5908019

object_name: cancer


subject: UMLS:C5908019

object_name: neoplasm


subject: UMLS:C5577555

subject_name: Opdualag


subject: UMLS:C5577555


subject: UMLS:C5577555


subject: UMLS:C5577555


subject: UMLS:C5577555


subject: UNII:SE2KH7T06F

object_name: ERBB2 Overexpression


subject: UMLS:C4287766


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:91758

object_name: migraine with aura


subject: CHEBI:91758

object_name: Common Migraine


subject: CHEBI:4562

subject_name: Dihydroergotamine


subject: CHEBI:4562


subject: CHEBI:7772

subject_name: omeprazole

object_name: glaucoma


subject: CHEBI:7772

object_name: Glaucoma, CTCAE


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Adenocarcinoma of the prostate stage III


subject: CHEBI:4672

object_name: Adenocarcinoma of the prostate stage II


subject: CHEBI:4672

object_name: Adenocarcinoma of the prostate stage I


subject: CHEBI:134730

subject_name: Umifenovir


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Recurrent disease


subject: CHEBI:7465

object_name: Global Relapse in Viscera


subject: CHEBI:7465

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:7465

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:7465

object_name: Global Relapse


subject: CHEBI:7465

object_name: Global Relapse in Skin


subject: CHEBI:7465

object_name: Global Relapse in Blood


subject: CHEBI:7465

object_name: Recurrence


subject: CHEBI:7465

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:7465

object_name: Recurrent tumor


subject: UMLS:C5855549

subject_name: Hyperpolarized Carbon 13 Alpha-ketoglutarate

object_name: Adult Mixed Glioma


subject: CHEBI:681569

subject_name: Clofarabine

object_name: lymphoblastic lymphoma


subject: CHEBI:681569

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:681569

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:681569

object_name: Burkitt lymphoma


subject: UMLS:C2962694

subject_name: Glucose 500 MG/ML includes Injection & Prefilled Syringe

object_name: Ehlers-Danlos syndrome


subject: UMLS:C2962694

object_name: Low back pain


subject: UMLS:C2962694

object_name: Sacroiliac instability


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: plasma cell myeloma


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: prostate cancer


subject: UMLS:C2346821

object_name: prostate neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:45716

subject_name: Vorinostat

object_name: prostate carcinoma


subject: CHEBI:45716


subject: CHEBI:45716

object_name: urinary bladder carcinoma


subject: CHEBI:45716

object_name: urinary bladder cancer


subject: CHEBI:45716

object_name: childhood bladder carcinoma


subject: CHEBI:45716

object_name: urothelial carcinoma


subject: DRUGBANK:DB16451


subject: CHEBI:80270

object_name: functional gastric disease


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: UNII:DOB7Y3RSX0

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: UNII:DOB7Y3RSX0

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:DOB7Y3RSX0

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:DOB7Y3RSX0

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UNII:DOB7Y3RSX0

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UNII:DOB7Y3RSX0

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UNII:DOB7Y3RSX0

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UNII:DOB7Y3RSX0

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UNII:DOB7Y3RSX0

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UNII:DOB7Y3RSX0

object_name: Verrucous carcinoma of the oral cavity stage I


subject: UNII:DOB7Y3RSX0

object_name: Verrucous carcinoma of the oral cavity stage II


subject: UNII:DOB7Y3RSX0

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:DOB7Y3RSX0

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UNII:DOB7Y3RSX0

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: Zinc deficiency


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: Tendinopathy


subject: CHEBI:78770

object_name: epicondylitis


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:2724258


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:46859


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Locally Advanced Head and Neck Carcinoma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Critical Illness


subject: CHEBI:74705

object_name: delirium


subject: CHEBI:74705

object_name: Delirium, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: brain neoplasm


subject: CHEBI:94518

object_name: astrocytoma


subject: CHEBI:94518

object_name: glioma


subject: UMLS:C1176021

object_name: colorectal neoplasm


subject: UMLS:C3852521

subject_name: AMG 232

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3852521

object_name: acute myeloid leukemia


subject: UMLS:C3852521

object_name: neoplasm


subject: UMLS:C3852521

object_name: cancer


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:2955

subject_name: Azithromycin

object_name: cesarean section; infection


subject: UMLS:C2826358

object_name: Stomach cancer


subject: UMLS:C2826358

object_name: gastric cancer


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: end stage renal failure


subject: CHEBI:194186

object_name: Chronic uremia


subject: CHEBI:194186

object_name: kidney failure


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:24950485

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:24950485

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:24950485

object_name: pancreatic adenocarcinoma


subject: UMLS:C4722545

object_name: diabetic polyneuropathy


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Childhood Breast Carcinoma


subject: MESH:D002136

object_name: breast carcinoma


subject: MESH:D002136

object_name: breast cancer


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEMBL.COMPOUND:CHEMBL2103737

subject_name: HYDROXOCOBALAMIN

object_name: vitamin B12 deficiency


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: inborn disorder of cobalamin metabolism and transport


subject: CHEBI:27786

subject_name: Hydroxocobalamin


subject: CHEBI:27732

subject_name: Caffeine

object_name: CYP1A2 polymorphism


subject: CHEBI:600103

subject_name: daptomycin

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:50249

subject_name: anticoagulant

object_name: venous thromboembolism


subject: CHEBI:50249

object_name: thrombophilia due to thrombin defect


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:9168

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:9168


subject: CHEBI:9168

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:9168


subject: CHEBI:9168

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: GTOPDB:13613

subject_name: lumasiran

object_name: primary hyperoxaluria type 1


subject: UNII:RZT8C352O1

subject_name: Lumasiran


subject: CHEBI:37168

subject_name: iota-carrageenan


subject: CHEBI:37168

object_name: severe acute respiratory syndrome


subject: DRUGBANK:DB15304

subject_name: iota-Carrageenan


subject: DRUGBANK:DB15304


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: plasma cell myeloma


subject: UMLS:C4053601


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB


subject: UMLS:C4329332

subject_name: Fianlimab


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: ureter transitional cell carcinoma


subject: CHEBI:72317

object_name: bladder transitional cell carcinoma


subject: CHEBI:72317

object_name: urethra transitional cell carcinoma


subject: CHEBI:72317

object_name: renal pelvis urothelial carcinoma


subject: CHEBI:72317

object_name: penis carcinoma


subject: CHEBI:72317

object_name: Invasive Sarcomatoid Urothelial Carcinoma


subject: CHEBI:72317

object_name: Genitourinary Cancer


subject: CHEBI:72317

object_name: plasmacytoid variant infiltrating bladder urothelial carcinoma


subject: CHEBI:72317

object_name: infiltrating bladder urothelial carcinoma sarcomatoid variant


subject: CHEBI:72317

object_name: bladder squamous cell carcinoma


subject: CHEBI:72317

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:72317

object_name: kidney medullary carcinoma


subject: CHEBI:72317

object_name: Stage IV Penile Cancer AJCC v8


subject: CHEBI:72317

object_name: urinary bladder small cell neuroendocrine carcinoma


subject: CHEBI:72317

object_name: Stage III Penile Cancer AJCC v8


subject: CHEBI:72317

object_name: Malignant Solid Neoplasm


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679

object_name: sarcomatoid renal cell carcinoma


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Stage IV Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:231679

object_name: Stage III Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: ureter transitional cell carcinoma


subject: CHEBI:231614

object_name: bladder transitional cell carcinoma


subject: CHEBI:231614

object_name: urethra transitional cell carcinoma


subject: CHEBI:231614

object_name: renal pelvis urothelial carcinoma


subject: CHEBI:231614

object_name: penis carcinoma


subject: CHEBI:231614

object_name: Invasive Sarcomatoid Urothelial Carcinoma


subject: CHEBI:231614

object_name: Genitourinary Cancer


subject: CHEBI:231614

object_name: plasmacytoid variant infiltrating bladder urothelial carcinoma


subject: CHEBI:231614

object_name: infiltrating bladder urothelial carcinoma sarcomatoid variant


subject: CHEBI:231614

object_name: bladder squamous cell carcinoma


subject: CHEBI:231614

object_name: Stage IV Penile Cancer AJCC v8


subject: CHEBI:231614

object_name: urinary bladder small cell neuroendocrine carcinoma


subject: CHEBI:231614

object_name: Stage III Penile Cancer AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: Renal rickets


subject: UNII:2P3VWU3H10

object_name: end stage renal failure


subject: UNII:2P3VWU3H10

object_name: Chronic uremia


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:27594


subject: CHEBI:27594


subject: UNII:5T4TX6CO53

object_name: narcolepsy


subject: UMLS:C1958615


subject: UMLS:C4054493

subject_name: Mimotope-P10s-PADRE Peptide Vaccine

object_name: triple-negative breast carcinoma


subject: UMLS:C4054493

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4054493

object_name: breast neoplasm


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: CHEBI:63623

subject_name: Succimer

object_name: pervasive developmental disorder


subject: CHEBI:63623

object_name: autism


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C3896914


subject: UNII:67GXQ6WCC6

subject_name: Oglemilast

object_name: exercise-induced bronchoconstriction


subject: UNII:67GXQ6WCC6

object_name: asthma


subject: UNII:67GXQ6WCC6

object_name: Exercise-induced asthma


subject: UNII:FKO8A7AD54

subject_name: Bocidelpar

object_name: kidney failure


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: skin neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: metastatic squamous cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: head and neck squamous cell carcinoma


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:8499

subject_name: Propranolol

object_name: vitamin D deficiency


subject: GTOPDB:10013

object_name: acute graft versus host disease


subject: UMLS:C4053675

subject_name: AbGn 168H


subject: CHEBI:142431

subject_name: Praliciguat

object_name: hypertension


subject: CHEBI:142431

object_name: Hypertension, CTCAE


subject: CHEBI:142431

object_name: type 2 diabetes mellitus


subject: UMLS:C5198199


subject: UMLS:C5198199


subject: UMLS:C5198199


subject: UMLS:C0078510

subject_name: Wobenzym

object_name: HIV infection


subject: UNII:7N13IK9LNH

object_name: ovarian cancer


subject: UNII:7N13IK9LNH

object_name: ovarian neoplasm


subject: UNII:7N13IK9LNH

object_name: ovarian carcinoma


subject: DRUGBANK:DB19041

subject_name: Elimusertib


subject: DRUGBANK:DB19041


subject: DRUGBANK:DB19041


subject: CHEBI:6801

subject_name: Metformin

object_name: intermittent vascular claudication


subject: UMLS:C5238976

subject_name: Negalstobart


subject: UMLS:C5238976

object_name: Neck Carcinoma


subject: UMLS:C5238976

object_name: head and neck neoplasm


subject: UMLS:C5238976

object_name: head and neck cancer


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Acute-On-Chronic Liver Failure


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:XNM7LT65NP

object_name: Adult bronchiectasis


subject: UMLS:C2698293

subject_name: Aztreonam lysine


subject: UMLS:C5417877

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C5417921


subject: CHEBI:68551

subject_name: Linaclotide

object_name: Irritable bowel syndrome characterized by constipation


subject: PUBCHEM.COMPOUND:9852982

subject_name: Ceftaroline

object_name: staphylococcal infection


subject: PUBCHEM.COMPOUND:9852982

object_name: Staphylococcal Skin Infections


subject: PUBCHEM.COMPOUND:9852982

object_name: skin disorder caused by infection


subject: PUBCHEM.COMPOUND:9852982

object_name: skin infection


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: PUBCHEM.COMPOUND:72562361


subject: PUBCHEM.COMPOUND:72562361


subject: PUBCHEM.COMPOUND:72562361


subject: UMLS:C1517701

subject_name: labetuzumab

object_name: colorectal cancer


subject: UMLS:C1517701

object_name: colorectal carcinoma


subject: UMLS:C1517701

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1517701

object_name: rectal carcinoma


subject: UMLS:C1517701

object_name: rectal cancer


subject: UMLS:C1517701

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1517701

object_name: colon carcinoma


subject: UMLS:C1517701

object_name: colon cancer


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: GTOPDB:8251


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UNII:EFE6X5M3UY


subject: UMLS:C4548795

object_name: inflammatory bowel disease


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Caesarean section


subject: PUBCHEM.COMPOUND:442108

subject_name: IBOGAINE

object_name: head injury trauma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: PTEN gene mutation


subject: CHEBI:9168

object_name: PTEN hamartoma tumor syndrome


subject: CHEBI:9168

object_name: Cowden disease


subject: CHEBI:9654

subject_name: Trazodone

object_name: spinal cord injury


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: prostate carcinoma


subject: CHEBI:8869

object_name: prostate cancer


subject: UNII:J932A2CDQO

subject_name: 5-methyl-2'-fluoroarauracil F-18


subject: UNII:J932A2CDQO

object_name: prostate neoplasm


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Blood glucose below reference range (finding)


subject: CHEBI:17925

object_name: Hypoglycemia, CTCAE


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: UNII:2P3VWU3H10

subject_name: ACTIVATED CHARCOAL

object_name: overdose


subject: UNII:2P3VWU3H10

object_name: Overdose


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:27594


subject: UMLS:C4721955

subject_name: Grass pollen extract

object_name: Atopic rhinitis


subject: UMLS:C4721955

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:6437

subject_name: Levetiracetam

object_name: kidney failure


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: dry eye syndrome


subject: PR:000004904

subject_name: complement C5


subject: CHEBI:48775


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: CHEBI:22977

subject_name: Cadmium


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Neuroendocrine carcinoma of pancreas


subject: CHEBI:31348

object_name: Intestinal Neuroendocrine Carcinoma


subject: CHEBI:31348

object_name: Gastric neuroendocrine carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093

object_name: Hay fever


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C5854568

subject_name: Oncolytic HSV-1 R130

object_name: Neck Carcinoma


subject: UMLS:C5854568

object_name: head and neck neoplasm


subject: UMLS:C5854568

object_name: head and neck cancer


subject: UMLS:C5854568

object_name: non-small cell lung carcinoma


subject: UMLS:C5854568

object_name: small cell lung carcinoma


subject: UMLS:C5854568

object_name: bronchogenic carcinoma


subject: CHEBI:49140

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:49140

object_name: Autoimmunity


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: PUBCHEM.COMPOUND:3367

object_name: Relapse multiple myeloma


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Clear-cell metastatic renal cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: Neoplasm of the genitourinary tract


subject: UNII:52CMI0WC3Y

object_name: benign urinary system neoplasm


subject: UNII:52CMI0WC3Y

object_name: urinary system neoplasm


subject: UNII:52CMI0WC3Y

object_name: urinary system disorder


subject: UNII:52CMI0WC3Y

object_name: kidney neoplasm


subject: UNII:52CMI0WC3Y

object_name: kidney disorder


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:LIX4M9AIVM

subject_name: N-acetylsulfanilyl chloride

object_name: Diabetic foot ulcer


subject: UniProtKB:Q9I9N6

subject_name: ASC_DANRE Apoptosis-associated speck-like protein containing a CARD (sprot)


subject: PR:000015781

subject_name: steryl-sulfatase


subject: PR:000013514

subject_name: apoptosis-associated speck-like protein containing a CARD


subject: UMLS:C2351034

object_name: focal epilepsy


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: candidiasis


subject: UMLS:C0532508


subject: UMLS:C1541521

subject_name: AMG 386

object_name: primary peritoneal carcinoma


subject: UMLS:C1541521

object_name: Primary Peritoneal Cancer


subject: UMLS:C1541521

object_name: fallopian tube carcinoma


subject: UMLS:C1541521

object_name: fallopian tube cancer


subject: UMLS:C1541521

object_name: ovarian cancer


subject: UMLS:C1541521

object_name: ovarian neoplasm


subject: UMLS:C1541521

object_name: ovarian carcinoma


subject: UMLS:C4727585

subject_name: Near Infrared Imaging Agent HS-196

object_name: Childhood Solid Neoplasm


subject: UMLS:C4727585

object_name: Adult Solid Neoplasm


subject: UMLS:C4727585

object_name: Solid Neoplasm


subject: CHEBI:8024

subject_name: Perindopril

object_name: Marfan syndrome


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:8499

subject_name: Propranolol

object_name: intervertebral disk degenerative disorder


subject: CHEBI:8499

object_name: lumbar disk degenerative disorder


subject: CHEBI:8499

object_name: lumbar disk disease


subject: CHEBI:8499

object_name: Fused vertebrae


subject: UMLS:C1709446

subject_name: paclitaxel-loaded polymeric micelle

object_name: pancreatic neoplasm


subject: UMLS:C1709446

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1709446

object_name: malignant pancreatic neoplasm


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:134689

subject_name: Rucaparib

object_name: prostate carcinoma


subject: CHEBI:134689

object_name: prostate cancer


subject: CHEBI:72296

subject_name: Apixaban

object_name: aortic valve disorder


subject: CHEBI:72296

object_name: aortic valve disease 1


subject: CHEBI:72296

object_name: Aortic Valve Disease, CTCAE


subject: UMLS:C1170447

subject_name: NovoLog Mix 70/30

object_name: latent autoimmune diabetes in adults


subject: MESH:C557525

subject_name: SB939 compound

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: breast neoplasm


subject: UMLS:C0790233

subject_name: Distilled water

object_name: Post-Operative Pain


subject: CHEBI:63624

subject_name: Telbivudine

object_name: liver carcinoma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Renal cell carcinoma recurrent


subject: CHEBI:79699

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C2976005

object_name: hyperaldosteronism


subject: UMLS:C2976005

object_name: Conn's syndrome


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: central nervous system cancer


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEBI:143658


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: major depressive disorder


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Bradyarrhythmia (disorder)


subject: CHEBI:5494

object_name: Bradycardia


subject: CHEBI:5494

object_name: Tachycardia by ECG Finding


subject: CHEBI:5494

object_name: Tachycardia


subject: CHEBI:5494

object_name: cardiac arrest


subject: CHEBI:5494

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:5494

object_name: Asystole, CTCAE 5.0


subject: CHEBI:5494

object_name: Asystole by ECG Finding


subject: CHEBI:5494

object_name: Asystole, CTCAE 3.0


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: CHEBI:94449


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:31547

subject_name: Eplerenone

object_name: myocardial infarction


subject: CHEBI:31547

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:31547

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: biliary atresia


subject: UMLS:C0085297

object_name: cholangitis


subject: UMLS:C3714111


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: cleft palate


subject: CHEBI:94518

object_name: isolated cleft palate


subject: CHEBI:94518

object_name: cleft palate on exam


subject: CHEBI:125354

subject_name: Plerixafor

object_name: leukemia


subject: CHEBI:125354

object_name: childhood leukemia


subject: UMLS:C1721343

subject_name: dorzolamide / timolol

object_name: retinal vein occlusion


subject: UMLS:C1721343

object_name: diabetic macular edema


subject: UMLS:C1721343

object_name: age-related macular degeneration


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: coronavirus covid-19 infection variant omicron


subject: CHEMBL.COMPOUND:CHEMBL2108210

subject_name: LAVENDER OIL

object_name: Delirium in old age


subject: UMLS:C1328192

subject_name: ADI PEG20

object_name: uveal melanoma


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Irritable bowel syndrome with diarrhea


subject: CHEBI:91514

subject_name: Mebeverine


subject: CHEMBL.COMPOUND:CHEMBL2108126

subject_name: PSYLLIUM HUSK


subject: DRUGBANK:DB11097

subject_name: Plantago seed


subject: CHEBI:165446

subject_name: Psyllic acid


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Insulin resistance


subject: CHEBI:41879

object_name: glucose intolerance


subject: CHEBI:41879

object_name: Glucose Intolerance, CTCAE


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: neuromyelitis optica


subject: UNII:3S252O2Z4X

subject_name: Emapalumab

object_name: Cytopenia


subject: UMLS:C4740903

subject_name: emapalumab-lzsg


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Adrenal Cancer


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: adrenal cortex carcinoma


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:6954

subject_name: Mitotane


subject: CHEBI:8884

subject_name: Rocuronium

object_name: spinal fracture


subject: CHEBI:10127

subject_name: Zonisamide

object_name: schizophrenia


subject: CHEBI:10127

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:4672

subject_name: Docetaxel

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: multiple sclerosis


subject: MESH:D013956

subject_name: Antithyroid Agents

object_name: Graves disease


subject: UMLS:C3273936

object_name: metastatic melanoma


subject: UMLS:C2830125


subject: CHEBI:15544

subject_name: Alprostadil

object_name: physiological sexual disorder


subject: PUBCHEM.COMPOUND:2767

object_name: bone chondrosarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: chondrosarcoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: glioma


subject: UNII:28X28X9OKV

object_name: malignant glioma


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:135125140


subject: PUBCHEM.COMPOUND:135125140


subject: PUBCHEM.COMPOUND:135125140

object_name: cholangiocarcinoma


subject: PUBCHEM.COMPOUND:135125140


subject: PUBCHEM.COMPOUND:135125140


subject: UMLS:C5446606

subject_name: Crelosidenib


subject: UMLS:C5446606


subject: UMLS:C5446606


subject: UMLS:C5446606


subject: UMLS:C5446606


subject: CHEBI:35111

subject_name: calcium monohydroxide

object_name: Carious exposure of pulp


subject: CHEBI:35150

subject_name: calcium hydroxide


subject: CHEBI:31341

subject_name: calcium dihydroxide


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:29191

subject_name: hydroxyl


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: MESH:C086631

subject_name: mineral trioxide aggregate


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Edema


subject: PUBCHEM.COMPOUND:24743936

object_name: Bilateral tonic-clonic seizure with generalized onset


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Upper limb pain


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:122666966

object_name: non-small cell lung carcinoma


subject: CHEBI:3223

subject_name: Buspirone

object_name: dysautonomia


subject: CHEBI:3223

object_name: autonomic nervous system disorder


subject: CHEBI:3223

object_name: dizziness


subject: CHEBI:3223

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:3223

object_name: Vertigo, CTCAE


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: UNII:VR86R11J7J

subject_name: mivebresib

object_name: myelofibrosis


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: diabetic retinopathy


subject: UNII:QC4F7FKK7I

object_name: Vitreous hemorrhage due to diabetes mellitus


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Severe Sepsis


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:22976653

object_name: Chronic uremia


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: CHEBI:64356

subject_name: Pregabalin

object_name: dacryocystitis


subject: UMLS:C5771998

object_name: diabetic neuropathy


subject: UMLS:C4764260

subject_name: PI3K-delta Inhibitor YY-20394

object_name: diffuse large B-cell lymphoma


subject: UMLS:C3272772

object_name: malignant pleural mesothelioma


subject: UMLS:C3272772


subject: UMLS:C5690659

object_name: Depressed mood


subject: UMLS:C4329337

subject_name: TAB 001

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5238987

object_name: pancreatic neoplasm


subject: UMLS:C5238987


subject: UMLS:C5238987

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854505

subject_name: Anti-DKK1 Monoclonal Antibody JS015


subject: UMLS:C5854505


subject: UMLS:C5854505


subject: CHEBI:73579

subject_name: Leu-Val


subject: CHEBI:73579


subject: CHEBI:194537

subject_name: Livermorium


subject: CHEBI:194537


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: UMLS:C1881413


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: PR:000003915


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: Dementia associated with Parkinson's Disease


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Stage II Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6435378

object_name: Stage I Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6435378

object_name: Bronchial Epithelial Dysplasia


subject: PUBCHEM.COMPOUND:6435378

object_name: Tobacco-Related Carcinoma


subject: CHEBI:70707

subject_name: Vilazodone

object_name: cannabis abuse


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: hepatic encephalopathy


subject: UMLS:C0770246

object_name: Cirrhosis


subject: UMLS:C0770246

object_name: liver cirrhosis


subject: UMLS:C0770246

object_name: liver disorder


subject: UMLS:C0770246

object_name: Ascites


subject: UMLS:C0770246

object_name: Ascites, CTCAE


subject: UMLS:C1832026

object_name: childhood neoplasm


subject: UMLS:C1832026

object_name: neoplastic syndrome


subject: UMLS:C1832026

object_name: cancer or benign tumor


subject: UMLS:C1832026

object_name: neoplasm


subject: UMLS:C0081420

subject_name: AaIT neurotoxin, Androctonus australis

object_name: immunodeficiency disease


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: migraine


subject: CHEBI:4903

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:4903

object_name: Menstrual migraine


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:231594


subject: CHEBI:231594


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Gardnerella vaginitis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:49668

subject_name: Gefitinib

object_name: renal cell carcinoma


subject: CHEBI:63631

subject_name: Topiramate

object_name: Self-injurious behavior


subject: UMLS:C5417986

subject_name: Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC

object_name: metastatic melanoma


subject: CHEBI:137064

subject_name: Galunisertib

object_name: pancreatic neoplasm


subject: CHEBI:137064

object_name: exocrine pancreatic carcinoma


subject: CHEBI:137064

object_name: malignant pancreatic neoplasm


subject: CHEBI:137064

object_name: Neoplasm Metastasis


subject: CHEBI:137064


subject: GTOPDB:10067

object_name: Transformed Mycosis Fungoides


subject: GTOPDB:10067

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C2986404


subject: UMLS:C2986404


subject: CHEBI:74564

subject_name: Lys-Lys

object_name: urolithiasis


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Renal transplant rejection


subject: CHEBI:6413

subject_name: Letrozole

object_name: Secondary malignant neoplasm of breast


subject: PR:000009758

subject_name: leptin

object_name: HIV infection


subject: CHEBI:32599

object_name: mean arterial pressure


subject: CHEBI:32599

object_name: Mean blood pressure


subject: CHEBI:32599

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: CHEBI:74705

subject_name: Met-Leu

object_name: pervasive developmental disorder


subject: CHEBI:74705

object_name: autism


subject: CHEBI:74705

object_name: autism spectrum disorder


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:16796

subject_name: Melatonin

object_name: relapsing-remitting multiple sclerosis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: bile duct adenocarcinoma


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3

object_name: endometrial serous adenocarcinoma


subject: CHEBI:143079

subject_name: D-Leucine

object_name: Allergic rhinoconjunctivitis


subject: UMLS:C3542918

subject_name: Docetaxel Lipid Microspheres


subject: CHEBI:63660

object_name: cardiovascular disorder


subject: CHEBI:63660

object_name: lipodystrophy


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: gastroesophageal adenocarcinoma


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:31248

subject_name: Azosemide

object_name: heart failure


subject: CHEBI:31248

object_name: congestive heart failure


subject: CHEBI:167574

subject_name: Semaglutide

object_name: peripheral vascular disease


subject: CHEBI:167574

object_name: peripheral arterial disease


subject: UNII:6ZJ8V3Q0H1

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:6ZJ8V3Q0H1

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:9014

subject_name: Salsalate


subject: UMLS:C4744512

subject_name: Zirconium Zr 89 DFO-Daratumumab

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:521372

object_name: Diabetes


subject: PUBCHEM.COMPOUND:521372

object_name: diabetes mellitus


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: angina unstable


subject: RXCUI:8375


subject: CHEBI:94789

subject_name: Trimetazidine


subject: CHEBI:94789


subject: CHEBI:90217

subject_name: Quizartinib

object_name: adult acute myeloid leukemia


subject: CHEBI:90217

object_name: childhood acute myeloid leukemia


subject: CHEBI:32188

subject_name: Tegafur

object_name: cervical cancer


subject: CHEBI:32188

object_name: cervical carcinoma


subject: CHEBI:31652

subject_name: Gimeracil


subject: CHEBI:31652


subject: UMLS:C2697510

object_name: Myelofibrosis due to another disorder


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: acute lymphoblastic leukemia


subject: CHEBI:39548

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:39548

object_name: acute myeloid leukemia


subject: CHEBI:39548

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:39548

object_name: childhood myelodysplastic syndrome


subject: CHEBI:39548

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:184196

object_name: Solid Neoplasm


subject: UMLS:C4048807


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: Chronic iridocyclitis


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: UMLS:C3179523


subject: UMLS:C4704930

subject_name: Neuronox

object_name: Urinary Urgency


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor

object_name: arthritis


subject: UMLS:C3854325

object_name: Arthritis, CTCAE


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:9758

object_name: clear cell renal carcinoma


subject: GTOPDB:9758

object_name: renal cell adenocarcinoma


subject: GTOPDB:9758

object_name: renal cell carcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: Normal renal function


subject: UMLS:C0981695

subject_name: Product containing paroxetine 20 mg/1 each oral tablet (clinical drug)

object_name: Depressed mood


subject: UMLS:C5555617

subject_name: PI3K-alpha Inhibitor HS-10352

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555617

object_name: breast carcinoma


subject: UMLS:C5555617

object_name: breast cancer


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Hepatic impairment


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Chronic uremia


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: coronary microvascular disorder


subject: CHEBI:28939

object_name: HIV infection


subject: UMLS:C5669585

subject_name: Xeruborbactam

object_name: bacterial infectious disease


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: social phobia


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Tachypnea


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C5227687

object_name: Secondary oxalosis


subject: UMLS:C5227687

object_name: Hyperoxaluria


subject: UMLS:C5227687

object_name: nephrolithiasis, calcium oxalate


subject: UMLS:C5227687

object_name: nephrolithiasis


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:6QVL057INT

object_name: diffuse intrinsic pontine glioma


subject: UNII:6QVL057INT

object_name: High grade glioma


subject: UNII:6QVL057INT

object_name: malignant glioma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:50634

object_name: pulmonary hypertension


subject: CHEBI:27690

subject_name: Acetazolamide


subject: UNII:DA43GW06P1

subject_name: Methazolamide


subject: CHEBI:6822


subject: UMLS:C3493806

object_name: alcohol abuse


subject: UMLS:C3493806

object_name: alcohol dependence


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Critical Illness


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: CHEBI:30021

subject_name: Selenomethionine

object_name: mucositis


subject: CHEBI:30021

object_name: Radiation Sickness


subject: CHEBI:30021

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:30021

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:30021

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:30021

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:30021

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:30021

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:30021

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:30021

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:30021

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:30021

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:30021

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:30021

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:30021

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:30021

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:30021

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:30021

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:30021

object_name: Chemotherapeutic Agent Toxicity


subject: CHEBI:30021

object_name: Xerostomia


subject: CHEBI:177533

subject_name: Quarfloxin

object_name: neuroendocrine neoplasm


subject: CHEBI:177533

object_name: carcinoid tumor


subject: CHEBI:177533

object_name: digestive system neuroendocrine neoplasm


subject: UMLS:C5447471

subject_name: CXCR2 Agonist MGTA-145

object_name: kidney failure


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Aggressive Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:93786


subject: CHEBI:93786


subject: DRUGBANK:DB19249

subject_name: Bos taurus colostrum

object_name: alcoholic hepatitis


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: lymphangioma


subject: CHEBI:192614

object_name: Rare lymphatic malformation


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UNII:F5Q3N98VAM

subject_name: CLOPIDOGREL RESINATE

object_name: coronary artery disorder


subject: UMLS:C1321997

subject_name: sodium chloride 3 %

object_name: Dysphagia


subject: UMLS:C1321997

object_name: Dysphagia, CTCAE


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: prostate carcinoma


subject: CHEBI:82677

object_name: prostate cancer


subject: UNII:B6E7K36KT8

subject_name: Cenegermin

object_name: dry eye syndrome


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: intervertebral disk degenerative disorder


subject: CHEBI:94518

object_name: lumbar disk degenerative disorder


subject: UMLS:C2699335

subject_name: cixutumumab


subject: UMLS:C2699335


subject: UNII:O0408QB48D

subject_name: Chlorsulfaquinoxaline

object_name: colorectal cancer


subject: UNII:O0408QB48D

object_name: colorectal carcinoma


subject: UNII:O0408QB48D

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:73012857


subject: PUBCHEM.COMPOUND:73012857


subject: PUBCHEM.COMPOUND:73012857


subject: CHEBI:33353

subject_name: technetium atom

object_name: eyelid sebaceous gland carcinoma


subject: CHEBI:73694

subject_name: Trp-Ser

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:73694

object_name: obesity


subject: CHEBI:73694

object_name: Obesity, CTCAE


subject: PR:000006435

subject_name: acyl-CoA wax alcohol acyltransferase 2


subject: PR:000006435


subject: PR:000006435


subject: CHEBI:48775

object_name: Cardiac involvement


subject: CHEBI:48775

object_name: scleroderma


subject: CHEBI:48775

object_name: systemic sclerosis


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: CHEBI:8673


subject: CHEBI:8673


subject: CHEBI:22977

subject_name: Cadmium


subject: CHEBI:22977


subject: CHEBI:22977


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: pancreatic adenocarcinoma


subject: UNII:53O87HA2QU

object_name: pancreatic neoplasm


subject: UNII:53O87HA2QU

object_name: malignant pancreatic neoplasm


subject: RXCUI:197444

subject_name: carbidopa 25 MG / levodopa 100 MG Oral Tablet

object_name: Chronic pain


subject: RXCUI:197444

object_name: opioid use


subject: RXCUI:197444

object_name: chronic pain (diagnosis)


subject: RXCUI:197444

object_name: Back Pain, CTCAE 5.0


subject: RXCUI:197444

object_name: Back pain


subject: RXCUI:197444

object_name: Back Pain, CTCAE 3.0


subject: RXCUI:197444

object_name: opiate dependence


subject: RXCUI:197444

object_name: Chronic low back pain


subject: RXCUI:197444

object_name: Back Injuries


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: PUBCHEM.COMPOUND:126961754

subject_name: Opioids


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: PUBCHEM.COMPOUND:126961754


subject: CHEBI:35482

subject_name: opioid analgesic


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: CHEBI:35482


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Blast Phase Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: Accelerated Phase Myeloproliferative Neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:231350


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: mucosal melanoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: choroiditis


subject: UNII:4D8F2Q45LQ

object_name: intermittent vascular claudication


subject: UNII:4D8F2Q45LQ

object_name: peripheral vascular disease


subject: UNII:4D8F2Q45LQ

object_name: peripheral arterial disease


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:16347


subject: CHEBI:16347


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: hypertriglyceridemia


subject: CHEBI:38545

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:38545

object_name: hypertriglyceridemia 1


subject: CHEBI:38545

object_name: hypercholesterolemia, autosomal dominant, type B


subject: CHEBI:38545

object_name: hyperlipoproteinemia type V


subject: PUBCHEM.COMPOUND:131954443

subject_name: Rovalpituzumab Tesirine

object_name: cancer


subject: PUBCHEM.COMPOUND:131954443

object_name: neoplasm


subject: UNII:P256HB60FF


subject: UNII:P256HB60FF


subject: UMLS:C3827079


subject: UMLS:C3827079


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: placental site trophoblastic tumor


subject: UNII:2S9ZZM9Q9V

object_name: epithelioid trophoblastic tumor


subject: UNII:2S9ZZM9Q9V

object_name: gestational trophoblastic neoplasm


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UMLS:C2346810


subject: UNII:LMQ24G57E9

subject_name: Daridorexant

object_name: Obstructive sleep apnea of adult


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Follicular Helper T-Cell Lymphoma


subject: CHEBI:4026

object_name: Nodal T-follicular helper cell lymphoma, follicular type


subject: CHEBI:4026

object_name: Follicular Helper T-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:4026

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: DRUGBANK:DB08937

object_name: colon adenocarcinoma


subject: CHEBI:90876

subject_name: Lonsurf


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: hyperparathyroidism


subject: UNII:T42P99266K

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: RXCUI:404914

subject_name: Caduet

object_name: inherited lipid metabolism disorder


subject: RXCUI:404914

object_name: Dyslipidemia


subject: RXCUI:404914

object_name: hypertension


subject: RXCUI:404914

object_name: Hypertension, CTCAE


subject: UMLS:C0751599

subject_name: Betantrone

object_name: chronic progressive multiple sclerosis


subject: UMLS:C0751599

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0015980

subject_name: interferon-beta


subject: UMLS:C0015980


subject: CHEBI:9332

subject_name: Sulfamethoxazole

object_name: abscess


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Heberden node


subject: CHEBI:44185

object_name: osteoarthritis, hand


subject: CHEBI:44185

object_name: Erosive osteoarthrosis


subject: MESH:C586899

subject_name: ragweed MATA MPL

object_name: IgE responsiveness, atopic


subject: UMLS:C0063205

subject_name: hylase

object_name: neuralgia


subject: UNII:U3UT1G2B9N

subject_name: Methyl hydrogen fumarate


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:95165

object_name: colon carcinoma


subject: CHEBI:95165

object_name: colorectal cancer


subject: CHEBI:95165

object_name: colon cancer


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection

object_name: chronic kidney disease


subject: UMLS:C5203351

object_name: Chronic uremia


subject: UMLS:C4048177

subject_name: furosemide injection


subject: UMLS:C4048177


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: CHEBI:8346

subject_name: Potassium Iodide

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:8346

object_name: non-Hodgkin lymphoma


subject: CHEBI:74559

subject_name: Lys-Ile


subject: CHEBI:74559


subject: UMLS:C2603401

subject_name: Ki


subject: UMLS:C2603401


subject: UMLS:C5447746

object_name: Myelodysplasia


subject: UMLS:C5447746

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C5447746

object_name: myoclonic dystonia 11


subject: UMLS:C5447746

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Premalignant Lesion


subject: UMLS:C2346820


subject: UMLS:C3265530

subject_name: soybean germ extract

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3265530

object_name: obesity


subject: UMLS:C3265530

object_name: Obesity, CTCAE


subject: GTOPDB:13804

subject_name: petrelintide

object_name: Overweight


subject: GTOPDB:13804

object_name: type 2 diabetes mellitus


subject: GTOPDB:13804


subject: GTOPDB:13804


subject: GTOPDB:13804


subject: DRUGBANK:DB19442

subject_name: Petrelintide


subject: DRUGBANK:DB19442


subject: DRUGBANK:DB19442


subject: DRUGBANK:DB19442


subject: DRUGBANK:DB19442


subject: CHEBI:48045

subject_name: Marizomib

object_name: cancer


subject: CHEBI:48045

object_name: neoplasm


subject: UMLS:C1570638


subject: UMLS:C1570638


subject: PUBCHEM.COMPOUND:145994617

object_name: hypertension


subject: PUBCHEM.COMPOUND:145994617

object_name: Hypertension, CTCAE


subject: UMLS:C3713669


subject: UMLS:C3713669


subject: CHEBI:28487

subject_name: Reserpine

object_name: amphetamine abuse


subject: UNII:H1FKG90039

subject_name: TREPROSTINIL DIOLAMINE

object_name: pulmonary hypertension, primary, 1


subject: UNII:H1FKG90039

object_name: pulmonary hypertension


subject: UNII:H1FKG90039

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:H1FKG90039

object_name: pulmonary arterial hypertension


subject: UMLS:C0939309

subject_name: Depakote ER

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Graft Rejection


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Adult Penile Carcinoma


subject: CHEBI:4672

object_name: penis carcinoma


subject: CHEBI:4672

object_name: penile cancer


subject: UMLS:C5238470

subject_name: Pegylated SN-38 Conjugate PLX038

object_name: Neoplasm of uncertain or unknown behavior of breast


subject: UMLS:C5238470

object_name: Breast problem


subject: CHEBI:90227

subject_name: Selumetinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:90227

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: prostate cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C2930557

object_name: acute coronary syndrome


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Buerger Disease


subject: CHEBI:51450

subject_name: Bosentan


subject: UNII:D959AE5USF

subject_name: clofazimine

object_name: mycobacterial infectious disease


subject: UNII:X8T9SBH9LL

subject_name: DIQUAFOSOL TETRASODIUM

object_name: dry eye syndrome


subject: UMLS:C1880350

subject_name: diquafosol tetrasodium


subject: UMLS:C2350759


subject: CHEBI:135983

subject_name: Teriparatide

object_name: osteogenesis imperfecta


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:73038

subject_name: Parecoxib

object_name: pharyngitis


subject: CHEBI:73038

object_name: Pharyngalgia


subject: CHEBI:73038

object_name: Sore Throat, CTCAE


subject: CHEBI:73038

object_name: Postoperative Complications


subject: GTOPDB:13708

subject_name: lepodisiran

object_name: Decreased liver function


subject: UNII:X4BE7S8PN9

subject_name: LEPODISIRAN


subject: UMLS:C5909025

subject_name: Lepodisiran


subject: CHEMBL.COMPOUND:CHEMBL2103737

subject_name: HYDROXOCOBALAMIN

object_name: Vasoplegia


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: heart valve disorder


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: coronary artery disorder


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: hypotension


subject: CHEMBL.COMPOUND:CHEMBL2103737

object_name: Hypotension, CTCAE


subject: CHEBI:27786

subject_name: Hydroxocobalamin


subject: CHEBI:27786


subject: CHEBI:27786


subject: CHEBI:27786


subject: CHEBI:27786


subject: CHEBI:27786


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: UNII:WP58SVM6R4

subject_name: Laronidase

object_name: Spinal Cord Compression, CTCAE


subject: UNII:WP58SVM6R4

object_name: Spinal cord compression


subject: UNII:WP58SVM6R4

object_name: lysosomal storage disease


subject: DRUGBANK:DB05173

object_name: acute myeloid leukemia


subject: CHEBI:60799

subject_name: Esketamine

object_name: Acquired phimosis


subject: CHEBI:60799

object_name: phimosis


subject: RXCUI:1670307

subject_name: tipiracil / trifluridine Oral Product

object_name: colorectal cancer


subject: RXCUI:1670307

object_name: colorectal carcinoma


subject: RXCUI:1670307

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: psychosis


subject: PUBCHEM.COMPOUND:53477758


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Generalized chronic periodontitis


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: Vascular calcification


subject: CHEBI:2567

object_name: arteriosclerosis disorder


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: migraine with aura


subject: UMLS:C0013227

object_name: Common Migraine


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:9907

subject_name: ursodiol

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:9907

object_name: morbid obesity


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Scleroderma renal crisis


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:9468

subject_name: Tetracaine

object_name: Adverse drug response


subject: CHEBI:174615

object_name: Splenomegaly


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:135449332


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:176724

subject_name: Etiracetam


subject: CHEBI:176724


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:90942

subject_name: Ixazomib

object_name: plasma cell leukemia


subject: CHEBI:90942

object_name: plasmacytoma


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: lymphedema


subject: UNII:C4V974V932

object_name: Lymphedema, CTCAE


subject: UNII:C4V974V932

object_name: lymphoid system disorder


subject: UNII:C4V974V932

object_name: congenital vascular malformation


subject: UNII:C4V974V932

object_name: vascular anomaly


subject: UNII:C4V974V932

object_name: vascular malformation


subject: UNII:C4V974V932

object_name: Lipedema


subject: UNII:C4V974V932

object_name: adiposis dolorosa


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Uterine hemorrhage


subject: PUBCHEM.COMPOUND:13559282

object_name: Uterine Hemorrhage, CTCAE


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:71025


subject: CHEBI:165828

subject_name: UpA

object_name: uterine fibroid


subject: CHEBI:165828

object_name: leiomyoma


subject: CHEBI:165828


subject: CHEBI:165828


subject: UNII:83G67E21XI

subject_name: Urokinase


subject: UNII:83G67E21XI


subject: UNII:83G67E21XI


subject: UNII:83G67E21XI


subject: PR:000012826

subject_name: urokinase-type plasminogen activator


subject: PR:000012826


subject: PR:000012826


subject: PR:000012826


subject: PR:000013171

subject_name: proline-rich acidic protein 1


subject: PR:000013171


subject: PR:000013171


subject: PR:000013171


subject: CHEBI:167308

subject_name: Dextromethadone

object_name: Otorhinolaryngologic Neoplasms


subject: CHEBI:167308

object_name: Childhood Breast Carcinoma


subject: CHEBI:167308

object_name: breast carcinoma


subject: CHEBI:167308

object_name: breast cancer


subject: CHEBI:167308

object_name: Neck Carcinoma


subject: CHEBI:167308

object_name: head and neck neoplasm


subject: CHEBI:167308

object_name: head and neck cancer


subject: CHEBI:167308

object_name: prostate carcinoma


subject: CHEBI:167308

object_name: prostate cancer


subject: CHEBI:167308

object_name: uterine cancer


subject: CHEBI:167308

object_name: tumor of uterus


subject: CHEBI:167308

object_name: carcinoma of esophagus


subject: CHEBI:167308

object_name: esophageal cancer


subject: CHEBI:167308

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:167308

object_name: neoplasm of esophagus


subject: CHEBI:167308

object_name: pancreatic neoplasm


subject: CHEBI:167308

object_name: exocrine pancreatic carcinoma


subject: CHEBI:167308

object_name: malignant pancreatic neoplasm


subject: CHEBI:167308

object_name: bladder tumor


subject: CHEBI:167308

object_name: urinary bladder carcinoma


subject: CHEBI:167308

object_name: urinary bladder cancer


subject: CHEBI:167308

object_name: childhood bladder carcinoma


subject: CHEBI:167308

object_name: colon carcinoma


subject: CHEBI:167308

object_name: colorectal cancer


subject: CHEBI:167308

object_name: colon cancer


subject: CHEBI:167308

object_name: ocular cancer


subject: CHEBI:167308

object_name: central nervous system cancer


subject: CHEBI:167308

object_name: Malignant neoplasm of the central nervous system


subject: MESH:C000626862

subject_name: D-methadone

object_name: Otorhinolaryngologic Neoplasms


subject: MESH:C000626862

object_name: Childhood Breast Carcinoma


subject: MESH:C000626862

object_name: breast carcinoma


subject: MESH:C000626862

object_name: breast cancer


subject: MESH:C000626862

object_name: Neck Carcinoma


subject: MESH:C000626862

object_name: head and neck neoplasm


subject: MESH:C000626862

object_name: head and neck cancer


subject: MESH:C000626862

object_name: prostate carcinoma


subject: MESH:C000626862

object_name: prostate cancer


subject: MESH:C000626862

object_name: uterine cancer


subject: MESH:C000626862

object_name: tumor of uterus


subject: MESH:C000626862

object_name: carcinoma of esophagus


subject: MESH:C000626862

object_name: esophageal cancer


subject: MESH:C000626862

object_name: Childhood Esophageal Carcinoma


subject: MESH:C000626862

object_name: neoplasm of esophagus


subject: MESH:C000626862

object_name: pancreatic neoplasm


subject: MESH:C000626862

object_name: exocrine pancreatic carcinoma


subject: MESH:C000626862

object_name: malignant pancreatic neoplasm


subject: MESH:C000626862

object_name: bladder tumor


subject: MESH:C000626862

object_name: urinary bladder carcinoma


subject: MESH:C000626862

object_name: urinary bladder cancer